Effect of chronic neuronal nitric oxide-synthase inhibition on arterial function and structure in spontaneously hypertensive rats

Journal of Physiology and Pharmacology

Volumn 63, Issue 1, 2012, Pages 23-28

  Cacanyiova, S ^a   Kristek, F ^a   Malekova, M ^a   Ondrias, K ^b  

^a INSTITUTE OF CHEMISTRY   (Slovakia)

^b INSTITUTE OF MOLECULAR PHYSIOLOGY AND GENETICS   (Slovakia)

Author keywords

7 nitroindazole; Arterial structure; Endothelial function; Hypertension; Neuronal nitric oxide synthase; Spontaneously hypertensive rat; Vasomotor activity

Indexed keywords

7 NITROINDAZOLE; ACETYLCHOLINE; NEURONAL NITRIC OXIDE SYNTHASE; 7-NITROINDAZOLE; ENZYME INHIBITOR; INDAZOLE DERIVATIVE; NORADRENALIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIAL WALL THICKNESS; ARTERY DIAMETER; ARTICLE; BODY WEIGHT; CARDIOVASCULAR PARAMETERS; CHRONIC DRUG ADMINISTRATION; CONTROLLED STUDY; ESSENTIAL HYPERTENSION; HEART WEIGHT; HEART WEIGHT BODY WEIGHT RATIO; MALE; MESENTERIC ARTERY; NONHUMAN; RAT; SPONTANEOUSLY HYPERTENSIVE RAT; SYSTOLIC BLOOD PRESSURE; THORACIC AORTA; VASCULAR ENDOTHELIUM; VASOCONSTRICTION; VASODILATATION; ANIMAL; BLOOD PRESSURE; CARDIOMEGALY; DRUG ANTAGONISM; DRUG EFFECT; ENZYMOLOGY; HEART; HYPERTENSION; METABOLISM; PATHOPHYSIOLOGY;

ANIMALS; AORTA, THORACIC; BLOOD PRESSURE; CARDIOMEGALY; ENZYME INHIBITORS; HEART; HYPERTENSION; INDAZOLES; MALE; MESENTERIC ARTERIES; NITRIC OXIDE SYNTHASE TYPE I; NOREPINEPHRINE; RATS; RATS, INBRED SHR;

EID: 84859132917     PISSN: 08675910     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Benter IF, Francis I, Cojocel C, Juggi JS, Yousif MH, Canatan H. Contribution of cytochrome P450 metabolites of arachidonic acid to hypertension and end-organ damage in spontaneously hypertensive rats treated with L-NAME. Auton Autacoid Pharmacol 2005; 25: 143-154.
2. Benter IF, Yousif MH, Anim JT, Cojocel C, Diz DI. Angiotensin-(1-7) prevents development of severe hypertensive and end-organ damage in spontaneously hypertensive rats treted with L-NAME. Am J Physiol 2006; 290: H684-H691.
3. de Gasparo M, Hess P, Clozel M, et al. Combination of low-dose valsartan and enalapril improves endothelial dysfunction and coronary reserve in Nω-nitro-L-arginine methyl ester-treated spontaneously hypertensive rats. J Cardiovasc Pharmacol 2002; 40: 789-800.
4. Li JS, Deng LY, Grove K, Deschepper CF, Schiffrin EL. Comparison of effect of endothelin antagonism and angiotensin-converting enzyme inhibition on blood pressure and vascular structure in spontaneously hypertensive rats treated with Nω-nitro-L-arginine methyl ester. Correlation with topography of vascular endothelin-1 gene expression. Hypertension 1996; 28: 188-195.
5. Pechanova O, Bernatova I, Babal P, et al. Red wine polyphenols prevent cardiovascular alterations in L-NAME-induced hypertension. J Hypertens 2004; 22: 1551-1559.
6. Ruiz-Marcos FM, Ortiz MC, Fortepiani LA, Nadal FJ, Atucha NM, J. Garcia-Estao J. Mechanisms of the increased pressor response to vasopressor in the mesenteric bed of nitric oxide-deficient hypertensive rats. Eur J Pharmacol 2001; 412: 273-279.
7. Sventek P, Li JS, Grove K, Deschepper CF, Schiffrin EL. Vascular structure and expression of endothelin-1 gene in L-NAME-treated spontaneously hypertensive rats. Hypertension 1996; 27: 49-55.
8. Hauser W, Sassmann A, Qadri F, Johren O, Dominiak P. Expression of nitric oxide synthase isoforms in hypothalamo-pituitary-adrenal axis during the development of spontaneous hypertension in rats. Brain Res Mol Brain Res 2005; 138: 198-204.
9. Quadri F, Carretero OA, Scicli AG. Centrally produced neuronal nitric oxide in the control of baroreceptor reflex sensitivity and blood pressure in normotensive and spontaneously hypertensive rats. Jpn J Pharmacol 1999; 81: 279-285.
10. Boulanger MC, Heymes C, Benessiano J, Geske RS, Levy BI, Vanhoutte PM. Neuronal nitric oxide synthase is expressed in rat vascular smooth muscle cells. Activation by angiotensin II in hypertension. Circ Res 1998; 83: 1271-1278.
11. Piech A, Dessy C, Havaux X, Feron O, Balligand JL. Differential regulation of nitric oxide synthases and their allosteric regulators in heart and vessels of hypertensive rats. Cardiovasc Res 2003; 57: 456-457.
12. Hojna S, Kadlecova M, Dobesova Z, Valouskova V, Zicha J, Kunes J. The participation of brain NO synthase in blood pressure control of adult spontaneously hypertensive rats. Mol Cell Biochem 2007; 297: 21-29.
13. Beierwaltes WH. Macula densa stimulation of renin is reversed by selective inhibition of neuronal nitric oxide synthase. Am J Physiol 1997; 272: R1359-R1364.
14. Ollerstam A, Skott O, Ek J, Persson AE, Thorup C. Effects of long-term inhibition of neuronal nitric oxide synthase on blood pressure and rennin release. Acta Physiol Scand 2001; 173: 351-358.
15. Wangensteen R, Sainz J, Rodriguez-Gomez I, Moreno JM, Osuna A, Vargas F. Chronic blockade of neuronal nitric oxide synthase does not affect long-term control of blood pressure in normal, saline-drinking or deoxycorticosterone- treated rats. Exp Physiol 2003; 88: 243-250.
16. Cacanyiova S, Kristek F, Gerova M, Krenek P, Klimas J. Effect of chronic nNOS inhibition on blood pressue, vasoactivity, and arterial wall structure in Wistar rats. Nitric Oxide 2009; 20: 304-310.
17. Kristek F, Cacanyiova S, Gerova M. Hypotrophic effect of long-term neuronal NO-synthase inhibition on heart and conduit arteries of the wistar rats. J Physiol Pharmacol 2009; 60: 21-27.
18. Moore PK, Wallace P, Gaffen Z, Hart SL, Babbedge RC. Characterisation of the novel nitric oxide synthase inhibitor 7-nitro indazole and related indazoles: antinociceptive and cardiovascular effects. Br J Pharmacol 1993; 110: 219-224.
19. Sedlakova B, Cacanyiova S, Ondrias K, Kristek F, Krizanova O. Effect of 7-nitroindazole on the expression of intracellular calcium channels in the kidney of spontaneously hypertensive rats. Gen Physiol Pharmacol 2009; 28: 225-232.
20. Moreno JM, Rodriguez Gomez I, Wangensteen R, et al. Mechanisms of hydrogen peroxide-induced vasoconstriction in the isolated perfused rat kidney. J Physiol Pharmacol 2010; 61: 325-332.
21. 2+ handling observed in the mesenteric arterial tree of spontaneously hypertensive rats. J Pharmacol Exp Ther 2005; 313: 359-367.
22. Salomonsson M, Arendshorst WJ. Norepinephrine-induced calcium signalling pathways in afferent arterioles of genetically hypertensive rats. Am J Physiol 2001; 281: F264-F272.
23. Hatanaka Y, Hobara N, Honghua J, et al. Neuronal nitric- oxide synthase inhibition facilitates adrenergic neurotransmission in rat mesenteric resistance arteries. J Pharmacol Exp Ther 2006; 316: 490-497.
24. Rabelo FA, Russo EM, Salgado MC, Coelho EB. Nonendothelial NO blunts sympathetic response of normotensive rats but not of SHR. Hypertension 2001; 38: 565-568.
25. Ferrer M, Sanchez M, Minoves N, Salaices M, Balfagon G. Aging increases neuronal nitric oxide release and superoxide anion generation in mesenteric arteries from spontaneously hypertensive rats. J Vasc Res 2003; 40: 509-519.
26. Briones AM, Alonso MJ, Marin J, Balfagon G, Salaices M. Influence of hypertension on nitric oxide synthase expression and vascular effets of lipopolysaccharide in rat mesenteric arteries. Br J Pharmacol 2000; 131: 185-194.
27. Berg T. Increased counteracting effect of eNOS and nNOS on an α1-adrenergic rise in total peripheral vascular resistance in spontaneous hypertensive rats. Cardiovasc Res 2005; 67: 736-744.
28. Ono H, Ono Y, Frohlich ED. Nitric oxide synthase inhibition in spontaneously hypertensive rats: systematic, renal, and glomerular hemodynamics. Hypertension 1995; 26: 249-255.
29. Vaskonen T, Mervaala E, Krogerus L, et al. Cardiovascular effects of chronic inhibition of nitric oxide synthesis and dietary salt in spontaneously hypertensive rats. Hypertens Res 1997; 20: 183-192.